New Oral Weight Loss Pill Approved, Game-Changer for Aussies
Sydney News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys new weight loss pill, Orforglipron (Foundayo), gets US approval, offering a needle-free alternative to GLP-one drugs. Australian clinics eagerly await TGA approval. Trials show significant weight loss, with Lilly pricing it at $149/month. Local bosses predict increased adherence and easier distribution. Lilly aims for approval in forty countries this year, with shares surging 6%. While not replacing injections, these pills could capture 20% of the market by 2030, despite mild side effects and a thyroid tumor warning.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/4ebc797b0117a5ee